These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 29024007)

  • 1. SNP mutations occurring in thyroid hormone receptor influenced individual susceptibility to triiodothyronine: Molecular dynamics and site-directed mutagenesis approaches.
    Liu Y; Qu K; Hai Y; Li X; Zhao L; Zhao C
    J Cell Biochem; 2018 Mar; 119(3):2604-2616. PubMed ID: 29024007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the binding of 3,3',5-triiodo-L-thyronine and its analogues to mutant human beta 1 thyroid hormone receptors: a model of the hormone binding site.
    Cheng SY; Ransom SC; McPhie P; Bhat MK; Mixson AJ; Wintraub BD
    Biochemistry; 1994 Apr; 33(14):4319-26. PubMed ID: 8155649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two resistance to thyroid hormone mutants with impaired hormone binding.
    Huber BR; Sandler B; West BL; Cunha Lima ST; Nguyen HT; Apriletti JW; Baxter JD; Fletterick RJ
    Mol Endocrinol; 2003 Apr; 17(4):643-52. PubMed ID: 12554782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization.
    Kitajima K; Nagaya T; Jameson JL
    Thyroid; 1995 Oct; 5(5):343-53. PubMed ID: 8563470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
    Piedrafita FJ; Ortiz MA; Pfahl M
    Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of glutamine 252 in the hormone-dependent transcriptional activity of the thyroid hormone beta1 nuclear receptor.
    Bhat MK; McPhie P; Cheng S
    Biochemistry; 1997 Apr; 36(14):4233-9. PubMed ID: 9100018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helix 12 dynamics and thyroid hormone receptor activity: experimental and molecular dynamics studies of Ile280 mutants.
    Souza PC; Barra GB; Velasco LF; Ribeiro IC; Simeoni LA; Togashi M; Webb P; Neves FA; Skaf MS; Martínez L; Polikarpov I
    J Mol Biol; 2011 Oct; 412(5):882-93. PubMed ID: 21530542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
    Ng L; Forrest D; Haugen BR; Wood WM; Curran T
    Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1.
    Takeda T; Nagasawa T; Miyamoto T; Minemura K; Hashizume K; Degroot LJ
    Thyroid; 2000 Jan; 10(1):11-8. PubMed ID: 10691308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant-selective thyromimetics for the chemical rescue of thyroid hormone receptor mutants associated with resistance to thyroid hormone.
    Shi Y; Ye H; Link KH; Putnam MC; Hubner I; Dowdell S; Koh JT
    Biochemistry; 2005 Mar; 44(12):4612-26. PubMed ID: 15779888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone.
    Meier CA; Dickstein BM; Ashizawa K; McClaskey JH; Muchmore P; Ransom SC; Menke JB; Hao EH; Usala SJ; Bercu BB
    Mol Endocrinol; 1992 Feb; 6(2):248-58. PubMed ID: 1569968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.
    Hayashi Y; Sunthornthepvarakul T; Refetoff S
    J Clin Invest; 1994 Aug; 94(2):607-15. PubMed ID: 8040316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
    Zavacki AM; Harney JW; Brent GA; Larsen PR
    Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.
    Wong R; Zhu XG; Pineda MA; Cheng SY; Weintraub BD
    Mol Med; 1995 Mar; 1(3):306-19. PubMed ID: 8529109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.
    Yagi H; Pohlenz J; Hayashi Y; Sakurai A; Refetoff S
    J Clin Endocrinol Metab; 1997 May; 82(5):1608-14. PubMed ID: 9141558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.
    Meier CA; Parkison C; Chen A; Ashizawa K; Meier-Heusler SC; Muchmore P; Cheng SY; Weintraub BD
    J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three novel mutations at serine 314 in the thyroid hormone beta receptor differentially impair ligand binding in the syndrome of resistance to thyroid hormone.
    Gurnell M; Rajanayagam O; Agostini M; Clifton-Bligh RJ; Wang T; Zelissen PM; van der Horst F; van de Wiel A; Macchia E; Pinchera A; Schwabe JW; Chatterjee VK
    Endocrinology; 1999 Dec; 140(12):5901-6. PubMed ID: 10579356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent dimerization properties of mutant beta 1 thyroid hormone receptors are associated with different dominant negative activities.
    Hao E; Menke JB; Smith AM; Jones C; Geffner ME; Hershman JM; Wuerth JP; Samuels HH; Ways DK; Usala SJ
    Mol Endocrinol; 1994 Jul; 8(7):841-51. PubMed ID: 7984146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mutations in the beta1-thyroid hormone receptor on the inhibition of T3 binding by desethylamiodarone.
    van Beeren HC; Bakker O; Chatterjee VK; Wiersinga WM
    FEBS Lett; 1999 Apr; 450(1-2):35-8. PubMed ID: 10350052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation.
    Nomura Y; Nagaya T; Tsukaguchi H; Takamatsu J; Seo H
    Endocrinology; 1996 Oct; 137(10):4082-6. PubMed ID: 8828460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.